Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Annexin A2 silencing induces G2 arrest of non-small cell lung cancer cells through p53-dependent and -independent mechanisms.

Wang CY, Chen CL, Tseng YL, Fang YT, Lin YS, Su WC, Chen CC, Chang KC, Wang YC, Lin CF.

J Biol Chem. 2012 Sep 21;287(39):32512-24. Epub 2012 Aug 2.

2.

C10ORF97 is a novel tumor-suppressor gene of non-small-cell lung cancer and a functional variant of this gene increases the risk of non-small-cell lung cancer.

Shi Y, Chen J, Li Z, Zhang Z, Yu H, Sun K, Wang X, Song X, Wang Y, Zhen Y, Yang T, Lou K, Zhang Y, Zhang G, Hu Y, Ji J, Hui R.

Oncogene. 2011 Sep 29;30(39):4107-17. doi: 10.1038/onc.2011.116. Epub 2011 Apr 18.

PMID:
21499297
3.

Loss of p53 and MCT-1 overexpression synergistically promote chromosome instability and tumorigenicity.

Kasiappan R, Shih HJ, Chu KL, Chen WT, Liu HP, Huang SF, Choy CO, Shu CL, Din R, Chu JS, Hsu HL.

Mol Cancer Res. 2009 Apr;7(4):536-48. doi: 10.1158/1541-7786.MCR-08-0422.

4.

p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.

Katiyar SK, Meeran SM, Katiyar N, Akhtar S.

Mol Carcinog. 2009 Jan;48(1):24-37. doi: 10.1002/mc.20453.

PMID:
18459128
6.

Xanthatin induces cell cycle arrest at G2/M checkpoint and apoptosis via disrupting NF-κB pathway in A549 non-small-cell lung cancer cells.

Zhang L, Ruan J, Yan L, Li W, Wu Y, Tao L, Zhang F, Zheng S, Wang A, Lu Y.

Molecules. 2012 Mar 26;17(4):3736-50. doi: 10.3390/molecules17043736.

7.

MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.

Liu J, Lu KH, Liu ZL, Sun M, De W, Wang ZX.

BMC Cancer. 2012 Nov 14;12:519. doi: 10.1186/1471-2407-12-519.

8.

RNAi-mediated silencing of Anxa2 inhibits breast cancer cell proliferation by downregulating cyclin D1 in STAT3-dependent pathway.

Zhang F, Wang Z, Yuan J, Wei X, Tian R, Niu R.

Breast Cancer Res Treat. 2015 Sep;153(2):263-75. doi: 10.1007/s10549-015-3529-6. Epub 2015 Aug 8.

PMID:
26253946
9.
10.

3p21.3 tumor suppressor gene H37/Luca15/RBM5 inhibits growth of human lung cancer cells through cell cycle arrest and apoptosis.

Oh JJ, Razfar A, Delgado I, Reed RA, Malkina A, Boctor B, Slamon DJ.

Cancer Res. 2006 Apr 1;66(7):3419-27.

13.

X-radiation induces non-small-cell lung cancer apoptosis by upregulation of Axin expression.

Han Y, Wang Y, Xu HT, Yang LH, Wei Q, Liu Y, Zhang Y, Zhao Y, Dai SD, Miao Y, Yu JH, Zhang JY, Li G, Yuan XM, Wang EH.

Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):518-26. doi: 10.1016/j.ijrobp.2009.05.040.

PMID:
19735876
14.

Proteasome inhibitor PS-341 induces growth arrest and apoptosis of non-small cell lung cancer cells via the JNK/c-Jun/AP-1 signaling.

Yang Y, Ikezoe T, Saito T, Kobayashi M, Koeffler HP, Taguchi H.

Cancer Sci. 2004 Feb;95(2):176-80.

15.

Modulation of p53, ErbB1, ErbB2, and Raf-1 expression in lung cancer cells by depsipeptide FR901228.

Yu X, Guo ZS, Marcu MG, Neckers L, Nguyen DM, Chen GA, Schrump DS.

J Natl Cancer Inst. 2002 Apr 3;94(7):504-13.

PMID:
11929951
16.

Effect of rapamycin, an mTOR inhibitor, on radiation sensitivity of lung cancer cells having different p53 gene status.

Nagata Y, Takahashi A, Ohnishi K, Ota I, Ohnishi T, Tojo T, Taniguchi S.

Int J Oncol. 2010 Oct;37(4):1001-10.

PMID:
20811722
17.

The transmembrane adaptor Cbp/PAG1 controls the malignant potential of human non-small cell lung cancers that have c-src upregulation.

Kanou T, Oneyama C, Kawahara K, Okimura A, Ohta M, Ikeda N, Shintani Y, Okumura M, Okada M.

Mol Cancer Res. 2011 Jan;9(1):103-14. doi: 10.1158/1541-7786.MCR-10-0340. Epub 2010 Dec 14.

18.

Cyr61, a member of CCN family, is a tumor suppressor in non-small cell lung cancer.

Tong X, Xie D, O'Kelly J, Miller CW, Muller-Tidow C, Koeffler HP.

J Biol Chem. 2001 Dec 14;276(50):47709-14. Epub 2001 Oct 11.

19.

P53-regulated long non-coding RNA TUG1 affects cell proliferation in human non-small cell lung cancer, partly through epigenetically regulating HOXB7 expression.

Zhang EB, Yin DD, Sun M, Kong R, Liu XH, You LH, Han L, Xia R, Wang KM, Yang JS, De W, Shu YQ, Wang ZX.

Cell Death Dis. 2014 May 22;5:e1243. doi: 10.1038/cddis.2014.201.

20.

NFV, an HIV-1 protease inhibitor, induces growth arrest, reduced Akt signalling, apoptosis and docetaxel sensitisation in NSCLC cell lines.

Yang Y, Ikezoe T, Nishioka C, Bandobashi K, Takeuchi T, Adachi Y, Kobayashi M, Takeuchi S, Koeffler HP, Taguchi H.

Br J Cancer. 2006 Dec 18;95(12):1653-62. Epub 2006 Nov 28.

Supplemental Content

Support Center